Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Feb 03, 2021 7:59am

71 Views

Post# 32456210

market depth

pecial terms and non-boardlot orders do not appear in Depth by Price +Vertical +Columnar +Horizontal

V:VXL Depth by Order @07:54:13

Bid			Ask
Broker	Size	Price	Price	Size	Broker
7 TD Sec	1,000	0.52	0.52	15,000	7 TD Sec
7 TD Sec	500	0.52	0.52	15,000	7 TD Sec
7 TD Sec	500	0.52	0.53	15,000	7 TD Sec
2 RBC	1,500	0.52	0.54	2,500	7 TD Sec
2 RBC	20,000	0.52	0.54	2,000	2 RBC
2 RBC	6,000	0.52	0.55	10,000	7 TD Sec
88 Credential	500	0.51	0.55	2,000	19 Desjardins
79 CIBC	2,000	0.50	0.55	5,000	79 CIBC
7 TD Sec	4,240	0.50	0.55	15,000	124 Questrade
7 TD Sec	500	0.495	0.56	3,600	19 Desjardins